239 related articles for article (PubMed ID: 19698042)
1. Usefulness of composite methionine-positron emission tomography/3.0-tesla magnetic resonance imaging to detect the localization and extent of early-stage Cushing adenoma.
Ikeda H; Abe T; Watanabe K
J Neurosurg; 2010 Apr; 112(4):750-5. PubMed ID: 19698042
[TBL] [Abstract][Full Text] [Related]
2. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
[TBL] [Abstract][Full Text] [Related]
3. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas.
Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H
Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of the characteristics and incidence of adenoma-associated dural invasion in Cushing disease.
Lonser RR; Ksendzovsky A; Wind JJ; Vortmeyer AO; Oldfield EH
J Neurosurg; 2012 Feb; 116(2):272-9. PubMed ID: 21923247
[TBL] [Abstract][Full Text] [Related]
5. CRH stimulation improves
Boyle J; Patronas NJ; Smirniotopoulos J; Herscovitch P; Dieckman W; Millo C; Maric D; Chatain GP; Hayes CP; Benzo S; Scott G; Edwards N; Ray Chaudhury A; Lodish MB; Sharma S; Nieman LK; Stratakis CA; Lonser RR; Chittiboina P
Endocrine; 2019 Jul; 65(1):155-165. PubMed ID: 31062234
[TBL] [Abstract][Full Text] [Related]
6. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z
J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
[TBL] [Abstract][Full Text] [Related]
7. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.
Prevedello DM; Pouratian N; Sherman J; Jane JA; Vance ML; Lopes MB; Laws ER
J Neurosurg; 2008 Oct; 109(4):751-9. PubMed ID: 18826366
[TBL] [Abstract][Full Text] [Related]
8. Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenomas: An Underestimated Entity.
Knappe UJ; Jaspers C; Buschsieweke D; Reinbold WD; Alomari A; Saeger W; Ehlenz K; Mann WA; Kann PH; Feldkamp J
Neurosurgery; 2017 Apr; 80(4):525-533. PubMed ID: 27352274
[TBL] [Abstract][Full Text] [Related]
9. A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome.
Koulouri O; Steuwe A; Gillett D; Hoole AC; Powlson AS; Donnelly NA; Burnet NG; Antoun NM; Cheow H; Mannion RJ; Pickard JD; Gurnell M
Eur J Endocrinol; 2015 Oct; 173(4):M107-20. PubMed ID: 26245763
[TBL] [Abstract][Full Text] [Related]
10. ACTH adenomas transforming their clinical expression: report of 5 cases.
Zoli M; Faustini-Fustini M; Mazzatenta D; Marucci G; De Carlo E; Bacci A; Pasquini E; Lanzino G; Frank G
Neurosurg Focus; 2015 Feb; 38(2):E15. PubMed ID: 25639317
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of preoperative magnetic resonance imaging of the pituitary for surgical cure in Cushing's disease.
Witek P; Zielinski G
Turk Neurosurg; 2012; 22(6):747-52. PubMed ID: 23208907
[TBL] [Abstract][Full Text] [Related]
12. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique.
Dehdashti AR; Gentili F
Neurosurg Focus; 2007; 23(3):E9. PubMed ID: 17961027
[TBL] [Abstract][Full Text] [Related]
13. Pituitary microadenomas: a PET study.
De Souza B; Brunetti A; Fulham MJ; Brooks RA; DeMichele D; Cook P; Nieman L; Doppman JL; Oldfield EH; Di Chiro G
Radiology; 1990 Oct; 177(1):39-44. PubMed ID: 2399336
[TBL] [Abstract][Full Text] [Related]
14. Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with cushing disease.
Batista D; Courkoutsakis NA; Oldfield EH; Griffin KJ; Keil M; Patronas NJ; Stratakis CA
J Clin Endocrinol Metab; 2005 Sep; 90(9):5134-40. PubMed ID: 15941871
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Evaluation of Sellar and Parasellar Macrolesions by [
Tosaka M; Higuchi T; Horiguchi K; Osawa T; Arisaka Y; Fujita H; Tsushima Y; Yoshimoto Y
World Neurosurg; 2017 Jul; 103():591-599. PubMed ID: 28427982
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of fused positron emission tomography/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing's disease.
Alzahrani AS; Farhat R; Al-Arifi A; Al-Kahtani N; Kanaan I; Abouzied M
Pituitary; 2009; 12(4):309-14. PubMed ID: 19387839
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of coregistered 11C-methionine positron emission tomography/3-T magnetic resonance imaging at the follow-up of acromegaly.
Rodriguez-Barcelo S; Gutierrez-Cardo A; Dominguez-Paez M; Medina-Imbroda J; Romero-Moreno L; Arraez-Sanchez M
World Neurosurg; 2014; 82(3-4):468-73. PubMed ID: 24239736
[TBL] [Abstract][Full Text] [Related]
18. Utility of hCRH-stimulated (18) F-FDG PET-CT scan in localisation of pituitary microadenoma in Cushing's disease.
Patt HP; Lele V; Lila A; Bandgar T; Shah N
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):213. PubMed ID: 24690246
[No Abstract] [Full Text] [Related]
19. Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions.
Pirotte BJ; Lubansu A; Massager N; Wikler D; Van Bogaert P; Levivier M; Brotchi J; Goldman S
J Neurosurg Pediatr; 2010 May; 5(5):479-85. PubMed ID: 20433262
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C
Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
